株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ドラッグデリバリー技術の世界市場予測 2021年:経口・経肺・注射・経眼・局所的・インプラント・経粘膜ドラッグデリバリー

Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 344812
出版日 ページ情報 英文 254 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.77円で換算しております。
Back to Top
ドラッグデリバリー技術の世界市場予測 2021年:経口・経肺・注射・経眼・局所的・インプラント・経粘膜ドラッグデリバリー Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting - Global Forecast to 2021
出版日: 2017年01月12日 ページ情報: 英文 254 Pages
概要

ドラッグデリバリー (薬剤送達) 技術の市場規模は、予測期間中に7.2%のCAGR (年間複合成長率) で推移し、2016年の1兆1,792億米ドルから、2021年までに1兆6,694億米ドルの規模に成長すると予測されています。慢性疾患の発症率の上昇、生物学的製剤の需要拡大、技術的進歩、および新製品発売などの要因が同市場の成長を推進しています。一方で、針刺し損傷および薬剤の副作用は同市場の成長を抑制する可能性があります。

当レポートでは、世界のドラッグデリバリー技術市場について調査し、市場の定義と概要、投薬経路および剤形の種類と概要、市場成長への各種影響因子および市場機会の分析、投薬経路・剤形・エンドユーザー・地域別の市場動向と市場規模の推移と予測、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 局所ドラッグデリバリー:市場概要
  • ドラッグデリバリー技術市場:利用施設別
  • 固形経口薬デリバリー技術市場:投与形態別
  • ドラッグデリバリー技術市場:投与経路別
  • ドラッグデリバリー技術市場の地域概要

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 推進因子
  • 阻害因子
  • 市場機会
  • 課題

第6章 規制状況

  • イントロダクション
  • 米国における薬剤認可
  • 欧州における薬剤認可

第7章 ドラッグデリバリー技術市場:投与経路別

  • イントロダクション
  • 経口ドラッグデリバリー
    • 固形経口薬
      • タブレット
      • カプセル
      • パウダー
      • ピル
    • 液体経口薬
      • 溶剤
      • シロップ
    • 半固形経口薬
      • ゲル
      • エマルジョン
      • エリキシル
  • 経肺ドラッグデリバリー
    • 剤形
    • デバイス
      • 計量吸入
      • ドライパウダー吸入
      • ネブライザー
        • ジェットネブライザー
        • 超音波ネブライザー
        • ソフトミストネブライザー
  • 注射ドラッグデリバリー
    • 注射器
      • 従来型注射器
        • 材料別
        • ガラス
        • プラスチック
        • 製品別
        • 充填可能シリンジ
        • 充填済みシリンジ
        • ユーザビリティ別
        • 再使用可能
        • ディスポーザル
      • 自己注射器
        • 無針注射器
        • オートインジェクター
        • ペン型注射器
        • ウェアラブル注射器
      • その他
    • 注射用製剤
      • 従来型製剤
      • 新型製剤
      • 長時間作用性製剤
  • 経眼ドラッグデリバリー
    • 剤形
      • 液体
        • 点眼剤
        • 液体スプレイ
      • 半固形
        • ゲル
        • 眼軟膏剤
    • 接眼デバイス
      • 薬剤塗膜コンタクトレンズ
      • 眼球インサート
  • 経鼻ドラッグデリバリー
    • 点鼻剤
    • スプレー
    • パウダー
    • ゲル
  • 局所的ドラッグデリバリー
    • 剤形
      • 液体局所ドラッグデリバリー
        • 溶剤
        • 懸濁剤
      • 半固形局所ドラッグデリバリー
        • クリーム
        • ゲル
        • 軟膏
        • ペースト
        • ローション
      • 固形
        • 座薬
        • パウダー
    • デバイス (経皮ドラッグデリバリー)
      • パッチ
      • ゲル
  • インプラントドラッグデリバリー
    • 能動型
    • 受動型
  • 経粘膜ドラッグデリバリー
    • 経口経粘膜
      • バッカル
      • 舌下
    • その他
      • 経肛門
      • 腟粘膜

第8章 ドラッグデリバリー技術市場:利用施設別

  • イントロダクション
  • 病院
  • 外来外科医療センター/クリニック
  • 在宅医療
  • 診断センター
  • その他

第9章 ドラッグデリバリー技術市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • その他の欧州 (ROE)
  • アジア
    • 日本
    • 中国
    • インド
    • その他のアジア
  • その他

第10章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向

第11章 企業プロファイル

  • イントロダクション
  • JOHNSON & JOHNSON SERVICES, INC.
  • NOVARTIS AG
  • F. HOFFMANN-LA ROCHE LTD.
  • PFIZER, INC.
  • BAYER AG
  • ANTARES PHARMA, INC.
  • BECTON, DICKINSON AND COMPANY
  • GLAXOSMITHKLINE PLC
  • 3M
  • MERCK & CO., INC.
  • SANOFI
    • 概要
    • 製品・サービス
    • 財務動向
    • 戦略
    • 近年の発展動向、など

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3871

The drug delivery technology market is projected to reach USD 1,669.40 billion by 2021 from USD 1,179.20 billion in 2016, at a CAGR of 7.2% during the forecast period.

Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are the factors driving the growth of this market. Whereas, self-administration & home care and rising demand for biosimilars and generic drugs offer significant growth opportunities for players operating in this market. On the other hand, risk of needle-stick injuries and side effects of drugs may restraint the growth of the market.

The drug delivery technology market is segmented based on route of administration, facility of use, and region. On the basis of route of administration, the market is segmented into oral, injectable, topical, nasal, ocular, pulmonary, implantable, and transmucosal. In 2016, the oral drug delivery segment is expected to account for the largest share of the market. This can be attributed to the wide range of benefits associated with oral drugs. The oral route of administration is one of the simplest, most convenient, and safest routes.

On the basis of facility of use, the market is segmented into the hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers, and other facilities of use. In 2016, the hospitals segment is expected to account for the largest share of the market. This can be primarily attributed to advantages such as the significant number of inpatient and outpatient visits in hospitals as compared to other end users and the requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool.

Asia is expected to be fastest-growing region in the drug delivery technology market from 2016 to 2021. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.

Prominent players in the drug delivery technology market include Johnson & Johnson, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), Novartis AG (Switzerland), 3M Company (U.S.), Becton, Dickinson and Company (U.S.), GlaxoSmithKline plc, (U.K.), Sanofi (France), and Antares Pharma, Inc. (U.S.).

Research Coverage:

The report defines, describes, and forecast the drug delivery technology market on the basis of route of administration, facility of use, and region. It provides detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, challenges). The study tracks and analyzes competitive developments such as joint ventures, mergers and acquisitions, new product developments, and expansions in the drug delivery technology market across to four main regions, namely, North America, Asia, Europe, and RoW.

Reasons to Buy the Report:

The report on the drug delivery technology market provides quantitative information for clients seeking market size information on various segments of this market. This report also provides access to the quantitative data on the drug delivery technology market.

This report covers

  • Current and forecast assessment of the drug delivery technology market.
  • Country-wise assessment of each of the segments
  • Global market share analysis for major segments of the drug delivery technology market
  • Adoption trends of various drug delivery technologies for major geographic markets
  • Five-year coverage of strategic developments of top players in the drug delivery technology market
  • Product Portfolio mapping of leading players in the drug delivery technology market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY DATA FROM SECONDARY SOURCES
  • 2.4. KEY DATA FROM PRIMARY SOURCES
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. TOPICAL DRUG DELIVERY: MARKET OVERVIEW
  • 4.2. DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE
  • 4.3. SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM
  • 4.4. DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION
  • 4.5. GEOGRAPHICAL SNAPSHOT OF THE DRUG DELIVERY TECHNOLOGY MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
  • 5.3. DRIVERS
    • 5.3.1. RISING PREVALENCE OF CHRONIC DISEASES
    • 5.3.2. GROWTH IN THE BIOLOGICS MARKET
    • 5.3.3. TECHNOLOGICAL ADVANCEMENT AND NEW PRODUCT LAUNCHES
  • 5.4. RESTRAINTS
    • 5.4.1. RISK OF NEEDLESTICK INJURIES AND SIDE EFFECTS OF DRUGS
    • 5.4.2. PRODUCT RECALLS
  • 5.5. OPPORTUNITIES
    • 5.5.1. SELF-ADMINISTRATION AND HOME CARE
    • 5.5.2. RISING DEMAND FOR BIOSIMILARS AND GENERIC DRUGS
      • 5.5.2.1. Biosimilars
      • 5.5.2.2. Generic drugs
    • 5.5.3. FOCUS ON OVERCOMING UNMET MEDICAL NEEDS
    • 5.5.4. EMERGING MARKETS
  • 5.6. CHALLENGES
    • 5.6.1. PATENT EXPIRY AND PATENT CLIFF
    • 5.6.2. PRICING PRESSURE

6. REGULATORY SCENARIO

  • 6.1. INTRODUCTION
  • 6.2. DRUG APPROVAL IN THE U.S.
  • 6.3. DRUG APPROVAL IN EUROPE

7. DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION

  • 7.1. INTRODUCTION
  • 7.2. ORAL DRUG DELIVERY
    • 7.2.1. SOLID ORAL DRUGS
      • 7.2.1.1. Tablets
      • 7.2.1.2. Capsules
      • 7.2.1.3. Powders
      • 7.2.1.4. Pills
    • 7.2.2. LIQUID ORAL DRUGS
      • 7.2.2.1. Solutions
      • 7.2.2.2. Syrups
    • 7.2.3. SEMI-SOLID ORAL DRUGS
      • 7.2.3.1. Gels
      • 7.2.3.2. Emulsions
      • 7.2.3.3. Elixirs
  • 7.3. PULMONARY DRUG DELIVERY
    • 7.3.1. FORMULATIONS
    • 7.3.2. DEVICES
      • 7.3.2.1. Metered Dose Inhalers
      • 7.3.2.2. Dry Powder Inhalers
      • 7.3.2.3. Nebulizers
        • 7.3.2.3.1. Jet nebulizers
        • 7.3.2.3.2. Ultrasonic nebulizers
        • 7.3.2.3.3. Soft mist nebulizers
  • 7.4. INJECTABLE DRUG DELIVERY
    • 7.4.1. DEVICES
      • 7.4.1.1. Conventional Injection Devices
        • 7.4.1.1.1. By material
        • 7.4.1.1.2. Glass
        • 7.4.1.1.3. Plastic
        • 7.4.1.1.4. By product
        • 7.4.1.1.4.1. Fillable syringes
        • 7.4.1.1.4.2. Prefilled syringes
        • 7.4.1.1.5. By usability
        • 7.4.1.1.5.1. Reusable syringes
        • 7.4.1.1.5.2. Disposable syringes
      • 7.4.1.2. Self-injection devices
        • 7.4.1.2.1. Needle-free injectors
        • 7.4.1.2.2. Autoinjectors
        • 7.4.1.2.3. Pen injectors
        • 7.4.1.2.4. Wearable injectors
      • 7.4.1.3. Other Injector Devices
    • 7.4.2. FORMULATIONS
      • 7.4.2.1. Conventional drug delivery
      • 7.4.2.2. Novel drug delivery formulations
      • 7.4.2.3. Long-acting injection formulations
  • 7.5. OCULAR DRUG DELIVERY
    • 7.5.1. FORMULATIONS
      • 7.5.1.1. Liquid Formulations
        • 7.5.1.1.1. Eye Drops
        • 7.5.1.1.2. Liquid Sprays
      • 7.5.1.2. Semi-solid Formulations
        • 7.5.1.2.1. Gels
        • 7.5.1.2.2. Eye Ointments
    • 7.5.2. OCULAR DEVICES
      • 7.5.2.1. Drug-coated Contact Lenses
      • 7.5.2.2. Ocular Inserts
  • 7.6. NASAL DRUG DELIVERY
    • 7.6.1. NASAL DROPS
    • 7.6.2. NASAL SPRAYS
    • 7.6.3. NASAL POWDERS
    • 7.6.4. NASAL GELS
  • 7.7. TOPICAL DRUG DELIVERY
    • 7.7.1. FORMULATIONS
      • 7.7.1.1. Liquid Topical Drug Delivery
        • 7.7.1.1.1. Solutions
        • 7.7.1.1.2. Suspensions
      • 7.7.1.2. Semi-solid topical drug delivery
        • 7.7.1.2.1. Creams
        • 7.7.1.2.2. Gels
        • 7.7.1.2.3. Ointments
        • 7.7.1.2.4. Pastes
        • 7.7.1.2.5. Lotions
      • 7.7.1.3. Solid topical drug delivery
        • 7.7.1.3.1. Suppositories
        • 7.7.1.3.2. Powders
    • 7.7.2. DEVICES (TRANSDERMAL DRUG DELIVERY)
      • 7.7.2.1. Transdermal patches
      • 7.7.2.2. Transdermal Gels
  • 7.8. IMPLANTABLE DRUG DELIVERY
    • 7.8.1. ACTIVE IMPLANTABLE DRUG DELIVERY
    • 7.8.2. PASSIVE IMPLANTABLE DRUG DELIVERY
  • 7.9. TRANSMUCOSAL DRUG DELIVERY
    • 7.9.1. ORAL TRANSMUCOSAL DRUG DELIVERY
      • 7.9.1.1. Buccal Drug Delivery
      • 7.9.1.2. Sublingual drug delivery
    • 7.9.2. OTHER TRANSMUCOSAL DRUG DELIVERY
      • 7.9.2.1. Rectal Transmucosal Drug Delivery
      • 7.9.2.2. Vaginal Transmucosal Drug Delivery

8. DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS
  • 8.3. AMBULATORY SURGICAL CENTERS/CLINICS
  • 8.4. HOME CARE SETTINGS
  • 8.5. DIAGNOSTIC CENTERS
  • 8.6. OTHER FACILITIES OF USE

9. DRUG DELIVERY TECHNOLOGY MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. REST OF EUROPE (ROE)
  • 9.4. ASIA
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATIONS & TRENDS
    • 10.3.1. PRODUCT LAUNCHES & APPROVALS
    • 10.3.2. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 10.3.3. ACQUISITIONS, MERGERS, AND JOINT VENTURES
    • 10.3.4. EXPANSIONS

11. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 11.1. INTRODUCTION
  • 11.2. JOHNSON & JOHNSON SERVICES, INC.
  • 11.3. NOVARTIS AG
  • 11.4. F. HOFFMANN-LA ROCHE LTD.
  • 11.5. PFIZER, INC.
  • 11.6. BAYER AG
  • 11.7. ANTARES PHARMA, INC.
  • 11.8. BECTON, DICKINSON AND COMPANY
  • 11.9. GLAXOSMITHKLINE PLC
  • 11.10. 3M
  • 11.11. MERCK & CO., INC.
  • 11.12. SANOFI

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER RECENT DEVELOPMENTS
  • 12.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RT: REAL-TIME MARKET INTELLIGENCE
  • 12.7. RELATED REPORTS
  • 12.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INDICATIVE LIST OF BIOLOGICS APPROVED BY FDA (2015 & 2016)
  • TABLE 2: MAJOR PRODUCT RECALLS IN THE DRUG DELIVERY TECHNOLOGY MARKET, 2015
  • TABLE 3: PATENT EXPIRY OF DRUGS, 2014-2015
  • TABLE 4: LIST OF REGULATORY AUTHORITIES, BY COUNTRY
  • TABLE 5: SOME OF THE RECENTLY APPROVED DRUGS BY FDA
  • TABLE 6: SOME OF THE RECENTLY APPROVED DRUGS IN EUROPE
  • TABLE 7: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 8: ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 9: ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 10: ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR SOLID DRUGS, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 11: ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR SOLID DRUGS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 12: SOLID ORAL DRUGS MARKET SIZE FOR TABLETS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 13: SOLID ORAL DRUGS MARKET SIZE FOR CAPSULES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 14: SOLID ORAL DRUGS MARKET SIZE FOR POWDERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 15: SOLID ORAL DRUGS MARKET SIZE FOR PILLS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 16: LIQUID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 17: LIQUID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 18: LIQUID ORAL DRUGS MARKET SIZE FOR SOLUTIONS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 19: LIQUID ORAL DRUGS MARKET SIZE FOR SYRUPS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 20: SEMI-SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 21: SEMI-SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 22: SEMI-SOLID ORAL DRUGS MARKET SIZE FOR GELS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 23: SEMI-SOLID ORAL DRUGS MARKET SIZE FOR EMULSIONS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 24: SEMI-SOLID ORAL DRUGS MARKET SIZE FOR ELIXIRS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 26: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 27: PULMONARY DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 28: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 29: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 30: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE FOR METERED DOSE INHALERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 31: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE FOR DRY POWDER INHALERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE FOR NEBULIZERS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 33: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE FOR NEBULIZERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: JET NEBULIZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: ULTRASONIC NEBULIZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: SOFT MIST NEBULIZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 38: INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 39: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 40: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 41: CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 42: CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 43: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 44: CONVENTIONAL FILLABLE INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 45: CONVENTIONAL PREFILLED INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 46: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY USABILITY, 2014-2021 (USD BILLION)
  • TABLE 47: CONVENTIONAL REUSABLE INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 48: CONVENTIONAL DISPOSABLE INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 49: SELF-INJECTION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 50: SELF-INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 51: NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 52: AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 53: COMMERCIALLY AVAILABLE KEY PEN INJECTORS
  • TABLE 54: PEN INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: WEARABLE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 56: OTHER INJECTOR DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 58: INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 59: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 60: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 61: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 62: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 63: LONG-ACTING INJECTION FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 64: OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 65: OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 66: OCULAR DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 67: OCULAR DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 68: LIQUID OCULAR FORMULATIONS MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 69: LIQUID OCULAR FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 70: COMMERCIALLY AVAILABLE EYE DROPS
  • TABLE 71: EYE DROPS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 72: LIQUID SPRAYS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 73: SEMI-SOLID OCULAR FORMULATIONS MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 74: SEMI-SOLID OCULAR FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 75: OCULAR GELS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 76: EYE OINTMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 77: OCULAR DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 78: OCULAR DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 79: DRUG-COATED CONTACT LENSES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 80: OCULAR INSERTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 81: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 82: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 83: NASAL DROPS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 84: NASAL SPRAYS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 85: NASAL POWDERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 86: NASAL GELS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 87: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 88: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 89: TOPICAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 90: TOPICAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 91: LIQUID TOPICAL FORMULATIONS MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 92 : IQUID TOPICAL FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 93 : OPICAL SOLUTIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 94 : OPICAL SUSPENSIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 95 : EMI-SOLID TOPICAL FORMULATIONS MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 96 : EMI-SOLID TOPICAL FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 97 : OPICAL CREAMS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 98 : OPICAL GELS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 99 : OPICAL OINTMENTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 100: TOPICAL PASTES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 101: TOPICAL LOTIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 102: SOLID TOPICAL FORMULATIONS MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 103: SOLID TOPICAL FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 104: TOPICAL SUPPOSITORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 105: TOPICAL POWDERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 106: TRANSDERMAL DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 107: TRANSDERMAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 108: TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 109: TRANSDERMAL GELS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 110: IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 111: IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 112: ACTIVE IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 113: PASSIVE IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 114: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 115: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 116: ORAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 117: ORAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 118: BUCCAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 119: SUBLINGUAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 120: OTHER TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 121: OTHER TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 122: RECTAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 123: VAGINAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 124: GLOBAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 125: GLOBAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 126: DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 127: DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR AMBULATORY SURGICAL CENTERS/CLINICS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 128: DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR HOME CARE SETTINGS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 129: DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR DIAGNOSTIC CENTERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 130: DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR OTHER FACILITIES OF USE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 131: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 132: NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 133: NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 134: NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 135: U.S.: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 136: U.S.: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 137: CANADA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 138: CANADA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 139: EUROPE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 140: EUROPE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 141: EUROPE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 142: GERMANY: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 143: GERMANY: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 144: FRANCE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 145: FRANCE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 146: U.K.: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 147: U.K.: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 148: ROE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 149: ROE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 150: ASIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 151: ASIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 152: ASIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 153: JAPAN: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 154: JAPAN: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 155: CHINA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 156: CHINA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 157: INDIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 158: INDIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 159: ROA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 160: ROA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD BILLION)
  • TABLE 161: ROW: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 162: ROW: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 163: PRODUCT LAUNCHES & APPROVALS, 2014-2016
  • TABLE 164: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2014-2016
  • TABLE 165: ACQUISITIONS, MERGERS, AND JOINT VENTURES, 2014-2016
  • TABLE 166: EXPANSIONS, 2014-2016
  • TABLE 167: EXCHANGE RATES (UTILIZED FOR CONVERSION OF CHF TO USD)
  • TABLE 168: EXCHANGE RATE (UTILIZED FOR CONVERSION OF EUR TO USD)
  • TABLE 169: EXCHANGE RATE (UTILIZED FOR CONVERSION OF GBP TO USD)
  • TABLE 170: EXCHANGE RATE (UTILIZED FOR CONVERSION OF EUR TO USD)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 1: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION (2016)
  • FIGURE 2: ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR SOLID DRUGS, BY DOSAGE FORM, 2016 VS. 2021 (USD BILLION)
  • FIGURE 3: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2016 VS. 2021 (USD BILLION)
  • FIGURE 4: DRUG DELIVERY TECHNOLOGY MARKET, BY REGION,
  • FIGURE 5 : ASE OF USE, RISING PREVALENCE OF CHRONIC DISEASES ARE DRIVING MARKET GROWTH
  • FIGURE 6 : OSPITALS SEGMENT TO HOLD LARGEST MARKET SHARE FROM 2016 TO 2021
  • FIGURE 7 : ABLETS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016
  • FIGURE 8 : RAL DRUG DELIVERY TO HOLD LARGEST SHARE IN THE MARKET IN 2016
  • FIGURE 9 : HINA TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 10: DRUG DELIVERY TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 11: TOPICAL DRUG DELIVERY TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: THE HOSPITALS SEGMENT IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE DRUG DELIVERY TECHNOLOGY MARKET IN 2016
  • FIGURE 13: NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 14: EUROPE: DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 15: ASIA: DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 16: ROW: DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 17: PRODUCT LAUNCHES & APPROVALS: KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE DRUG DELIVERY TECHNOLOGY MARKET (2014-2016)
  • FIGURE 18: GLOBAL DRUG DELIVERY TECHNOLOGY MARKET SHARE, BY KEY PLAYER (2015)
  • FIGURE 19: MARKET EVOLUTION FRAMEWORK: PRODUCT LAUNCHES & APPROVALS ARE FUELING MARKET GROWTH
  • FIGURE 20: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES & APPROVALS IS THE KEY GROWTH STRATEGY ADOPTED BY LEADING MARKET PLAYERS
  • FIGURE 21: GEOGRAPHIC REVENUE MIX FOR THE TOP 5 PLAYERS
  • FIGURE 22: JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 23: NOVARTIS AG: COMPANY SNAPSHOT (2015)
  • FIGURE 24: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2015)
  • FIGURE 25: PFIZER, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 26: BAYER AG: COMPANY SNAPSHOT (2015)
  • FIGURE 27: ANTARES PHARMA, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 28: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2015)
  • FIGURE 29: GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2015)
  • FIGURE 30: 3M: COMPANY SNAPSHOT (2015)
  • FIGURE 31: MERCK & CO., INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 32: SANOFI: COMPANY SNAPSHOT (2015)
Back to Top